You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Pharmobedient Cnsltg Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PHARMOBEDIENT CNSLTG, and what generic and branded alternatives to PHARMOBEDIENT CNSLTG drugs are available?

PHARMOBEDIENT CNSLTG has fourteen approved drugs.



Summary for Pharmobedient Cnsltg
US Patents:0
Tradenames:14
Ingredients:14
NDAs:14

Drugs and US Patents for Pharmobedient Cnsltg

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmobedient Cnsltg VALPROIC ACID valproic acid SYRUP;ORAL 070868-001 Jul 1, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe
Pharmobedient Cnsltg CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074757-001 Oct 17, 1997 DISCN No No ⤷  Subscribe ⤷  Subscribe
Pharmobedient Cnsltg PREDNISOLONE prednisolone SYRUP;ORAL 040313-001 Sep 10, 2003 DISCN No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.